Hinsdale Hematology-Oncology Associates joins Illinois Cancer Specialists


Nearly 20 physicians unite to advance patient services throughout the Chicago area 

Chicago and The Woodlands, Texas (September 26, 2012) — Illinois Cancer Specialists (ICS), united in healing with The US Oncology Network, announced today that Hinsdale Hematology-Oncology Associates (HHOA) will join its oncology and hematology practice to expand and enhance patient services in Chicago and the surrounding areas. 

The six board-certified physicians currently with HHOA will join the 12 oncologists of ICS to offer state-of-the-art, comprehensive cancer care and enhanced services to oncology and hematology patients in the comfort and convenience of a community setting. 

“We at Hinsdale Hematology-Oncology Associates combine our years of professional experience, judgment and skill with a dedication to evidence-based medicine to provide patients with high-quality, compassionate care,” said Donald L. Sweet, M.D., F.A.C.P., president, HHOA and director of Adventist Hinsdale Hospital’s cancer center. “In uniting with Illinois Cancer Specialists, we can collaborate with other like-minded physicians to advance cancer care even further and improve the patient experience.” 

Illinois Cancer Specialists is united in healing with The US Oncology Network, one of the nation’s largest networks of community-based oncologists dedicated to advancing cancer care in America. By joining ICS, physicians from HHOA will have access to Level I Pathways, physician-led evidence-based treatment guidelines, as well as opportunities to collaborate with an expanded physician community, including network-wide physician committees and conferences, and The Oncology Portal, where approximately 1,000 physicians can share best practices and collaborate on complex cases. 

“We are excited to have the physicians of Hinsdale join our practice,” said David Hakimian, M.D., medical oncologist, ICS. “We have a shared vision and dedication to high-quality cancer care and state-of-the art research. This collaboration will not only benefit our practice, but more importantly our patients and the care they receive. They will have two additional location options as well as access to another six physicians committed to helping them beat their disease.”

Illinois Cancer Specialists provides Chicago area patients with advanced, comprehensive, compassionate cancer care. The expanded practice employs the latest technologies and drug therapies to ensure patients receive high-quality care for their particular diagnosis in a collaborative, comprehensive setting. ICS treatment centers feature outpatient treatment and diagnostic facilities including chemotherapy, radiation therapy, positron emission tomography (PET), computerized tomography (CT), stem cell transplant, clinical research, laboratory, x-ray studies and specialized pharmaceuticals.

Given the recent merger with HHOA, Illinois Cancer Specialists now serves the communities in and around the Chicago area with five locations including Hinsdale, Bolingbrook, Arlington Heights, Chicago and Niles. 

About Illinois Cancer Specialists

Illinois Cancer Specialists (ICS) is dedicated to providing convenient, compassionate and leading-edge cancer care to patients in Chicago and the surrounding areas. With nearly 20 physicians and five locations, ICS brings patients advanced cancer care, along with the tools, resources and support they need to help them through their cancer journey. ICS is proud to offer more: more physician collaboration, more clinical trials and more convenient locations. Find out how patients are a priority at Illinois Cancer Specialists, by visiting www.OurOnlyCareisYou.com

Illinois Cancer Specialists is united in healing with The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks focused on advancing cancer care in America. As an affiliate of The US Oncology Network, ICS is united with approximately 1,000 physicians and 10,000 cancer care professionals nationwide. Illinois Cancer Specialists participates in clinical trials through US Oncology Research, which has helped to develop 43 FDA approved cancer therapies. For more information, visit www.usoncology.com

About Hinsdale Hematology-Oncology Associates

Hinsdale Hematology-Oncology Associates is a medical specialty group of doctors and allied healthcare professionals concentrating on the care of patients with cancer or disorders of the blood. The physicians in this practice are on the staff of Adventist Hinsdale and Adventist Bolingbrook Hospitals. In addition, all participate in several national research consortiums - the Eastern Cooperative Oncology Group (ECOG) and the National Surgical Adjuvant Breast and Bowel Project (NSABP). Through these and other affiliations, HHOA is able to offer state of the art medical care and special services such as experimental chemotherapy, immunologic and biologic modifier therapy, and cancer genetic risk assessment. For more information, visit www.hhoaltd.com

Media Contacts:
Claire Crye
McKesson Specialty Health
(281) 863-6783

Christy Sullivan
Illinois Cancer Specialists
(847) 421-4919


Click here to view PDF of press release.